FindTrial
Sign In

Predictive model for tacrolimus precision dosage in patients with organ transplantation

Predictive model for tacrolimus precision dosage in patients with organ transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018272
Enrollment
Unknown
Registered
2018-09-07
Start date
2018-10-09
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ transplantation

Interventions

Case series:NA

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who received heart, liver, or renal transplantation for the first time; (2) Patients aged 18~70 year; (3) Patients who received renal or heart transplantation are on triple immunosuppressive protocol which included tacrolimus, mycophenolate mofetil, and corticosteroids. The immunosuppressive regimen is based on tacrolimus for liver transplantation patients; (3) Patients data related to this study can be completely obtained.

Exclusion criteria

Exclusion criteria: (1) Patients who received two or mutiple organ transplantation; (2) Patients who is complicated with cancer; (3) Pregnant women and nursing mothers; (4) Patients with a poor adherence of tacrolimus during therapy.

Design outcomes

Primary

MeasureTime frame
NA;—

Countries

China

Contacts

Public ContactZhang Yu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

whxhzy@163.com+86 13971292838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026